For decades, creatine lived in the shadow of weight rooms and protein shakers, its story told almost entirely by men. Now, women in their thirties, forties, and fifties are rewriting that story — drawn not by the pursuit of bulk, but by emerging science suggesting creatine may quietly shore up the brain, the body, and the self during one of life's most demanding transitions. What is unfolding is less a fitness trend than a reckoning with how long women's physiology has been an afterthought in nutritional research.
Creatine's New Audience: Why Women Are Embracing the Brain-Boosting Supplement
Women start from a baseline deficit that makes them especially responsive.
Mark
So creatine sales jumped 120 percent in just over a year. That's a huge swing. What actually changed?
Mimi
The customer base changed. Women in their thirties through fifties started buying it, driven by research showing it might help with brain fog during menopause and perimenopause. Halle Berry talking about it publicly probably accelerated that.
Luke
But how much of that 120 percent growth is actually women versus just general market expansion? The source doesn't break down the sales by gender.
Mimi
That's fair. We know women are driving the growth—the reporting says so—but you're right that we don't have a percentage of the total.
Mark
Why would creatine help with menopause specifically? That seems like a leap.
Mimi
It's not really a leap. Estrogen declines during menopause, and that affects creatine stores in the brain. A trial called CONCRET-MENOPA showed that women taking creatine improved their reaction time and increased brain creatine levels by over sixteen percent.
Luke
One trial of thirty-six people over eight weeks. That's real data, but it's preliminary. We shouldn't overstate it.
Mimi
Absolutely. But it's the first double-blind RCT specifically testing this in menopausal women, so it's a meaningful starting point.
Mark
What about the bulking concern? That seems like the thing keeping women away.
Mimi
Women have about fifteen to twenty times less testosterone than men, so the physiology just doesn't support significant muscle growth from creatine. What happens is water retention inside muscle cells, which actually supports muscle protein synthesis.
Luke
That's the mechanism, but does the average woman taking creatine actually see that distinction, or does she just see the scale go up?
Mimi
That's the education gap. The science is clear, but the messaging hasn't caught up.
Mark
Is it safe long-term?
Mimi
A 2025 analysis of 685 clinical trials found no significant difference in side effects between creatine and placebo. The CONCRET-MENOPA trial had no severe adverse effects.
Luke
Though anyone with kidney issues should check with a doctor first, and we don't have decades of data on long-term use in this population.
Mimi
True. But for most healthy women, the safety profile looks solid based on what we know now.
O Pulso
- Creatine sales surged 120% in a single year, with women — not bodybuilders — leading the charge, signaling a fundamental shift in who wellness science is finally speaking to.
- The fear that creatine causes unwanted bulk has kept many women away for years, despite the fact that women produce far too little testosterone for that outcome to be physiologically possible.
- Perimenopausal and menopausal women face a compounding disadvantage: they naturally consume and synthesize less creatine than men, precisely when declining estrogen is already eroding muscle, bone, and brain function.
- The first double-blind trial focused specifically on menopausal women found measurable gains in reaction time and a 16% increase in frontal brain creatine levels — early but striking evidence that the brain, not just the body, stands to benefit.
- A review of 685 clinical trials found no meaningful difference in adverse events between creatine and placebo, offering a reassuring safety floor as more women consider adding it to their daily routine.
For decades, creatine lived in the shadow of weight rooms and protein shakers, its story told almost entirely by men. Now, women in their thirties, forties, and fifties are rewriting that story — drawn not by the pursuit of bulk, but by emerging science suggesting creatine may quietly shore up the brain, the body, and the self during one of life's most demanding transitions. What is unfolding is less a fitness trend than a reckoning with how long women's physiology has been an afterthought in nutritional research.
Creatine's reputation was built in gyms, by men, over decades. But retail data tracking a fifty-two-week period through March 2023 tells a different story now: sales climbed 120 percent, and the people driving that growth are women in their thirties, forties, and fifties. Halle Berry gave the shift a public face when she told her podcast audience she takes creatine daily to fight the mental fog of menopause — a personal testimony that happens to align with a growing body of clinical research.
The compound itself is neither exotic nor new. The body produces creatine naturally in the liver, kidneys, and pancreas, and people consume it through red meat and fish. But women begin at a structural disadvantage: research published in May 2025 found they consume roughly twenty to thirty percent less dietary creatine than men and synthesize it at lower rates. That baseline deficit may be precisely why women respond so strongly to supplementation — and the gap widens after menopause, when falling estrogen accelerates muscle loss, weakens bones, and disrupts brain function.
The most stubborn obstacle to adoption has been the fear of bulking up. It is understandable but physiologically unfounded. Women produce fifteen to twenty times less testosterone than men, making significant muscle hypertrophy from creatine essentially impossible. What the supplement actually does is enhance the body's ATP energy production during intense effort, supporting leaner muscle over time. Early water retention occurs inside muscle cells — a mechanism that promotes muscle protein synthesis — not beneath the skin.
The clinical evidence specific to menopausal women is still limited but pointed. The CONCRET-MENOPA trial, the first double-blind randomized controlled study of its kind, gave thirty-six perimenopausal and menopausal women either 1,500 milligrams of creatine HCl daily or a placebo for eight weeks. The creatine group improved reaction time by 6.6 percent versus 1.2 percent for placebo, and frontal brain creatine levels rose by 16.4 percent — the first direct human evidence of this effect in menopausal women. A separate study from St. Olaf College found meaningful gains in lower body strength and, unexpectedly, improved sleep quality among perimenopausal participants.
The cognitive connection makes biological sense. As estrogen falls, brain creatine stores can decline at the very moment neural function is most vulnerable. Creatine supplementation appears to replenish those stores, supporting memory, mood, and processing speed. On safety, a 2025 review of 685 clinical trials found no significant difference in adverse events between creatine and placebo groups. Women with kidney concerns or complex medication regimens should speak with a clinician first, but for most, daily use at three to five grams of creatine monohydrate appears well-tolerated. The supplement has not changed — only the long-overdue recognition of who it was always capable of helping.
Creatine sales climbed 120 percent over a fifty-two-week span ending in March 2023, according to retail tracking data, but the supplement's customer base has shifted dramatically. The people buying it now are not the bodybuilders and gym regulars who built creatine's reputation decades ago. They are women in their thirties, forties, and fifties, many of them drawn by emerging research suggesting the compound does far more than support muscle gains. Studies increasingly point to benefits for brain function, sleep quality, and the muscle and bone changes that accompany perimenopause and menopause. Halle Berry has become the public face of this shift, telling her podcast audience that she takes creatine daily to combat the mental fog that accompanied her menopause, a claim that sits atop a growing body of scientific evidence.
Creatine itself is not exotic. The body manufactures it naturally in the liver, kidneys, and pancreas. About ninety-five percent accumulates in skeletal muscle, with the remaining five percent distributed to the brain and heart. People consume it through ordinary food—red meat and fish are the primary sources—and both men and women produce it endogenously. But women start from a disadvantage. Research published in the Journal of the International Society of Sports Nutrition in May 2025 found that women consume roughly twenty to thirty percent less dietary creatine than men and synthesize it at lower rates naturally. This baseline deficit may explain why women respond so robustly to supplementation. The situation intensifies after menopause, when declining estrogen accelerates muscle loss, weakens bone density, and alters brain function—all areas where creatine has demonstrated measurable benefit.
The most persistent barrier to adoption among women is a single fear: that creatine will make them bulky. The concern is understandable but physiologically unfounded. Women produce approximately fifteen to twenty times less testosterone than men, making significant muscle hypertrophy from creatine essentially impossible. What creatine actually does is enhance ATP energy production during intense physical effort, allowing for harder training sessions that, over time, support lean muscle development. The initial weight gain some people experience comes from water retention inside muscle cells—a mechanism that triggers muscle protein synthesis—not cosmetic bloating beneath the skin.
The clinical evidence for creatine's effects on menopausal women remains sparse but suggestive. The CONCRET-MENOPA trial, published in the Journal of the American Nutrition Association, was the first double-blind randomized controlled trial to specifically examine creatine in perimenopausal and menopausal women. Thirty-six participants received either a medium dose of 1,500 milligrams per day of creatine HCl or placebo over eight weeks. Those taking creatine improved their reaction time by 6.6 percent compared to 1.2 percent in the placebo group, and their frontal brain creatine levels increased by 16.4 percent. A separate study from St. Olaf College in July 2025, involving fifteen perimenopausal and postmenopausal women, found significant gains in lower body strength and notable improvements in sleep quality among perimenopausal participants—a benefit not typically associated with the supplement.
The mechanism linking creatine to cognitive improvement during menopause is straightforward. As estrogen declines, creatine stores in the brain can fall precisely when neural function is most vulnerable. Research reported in May 2026 on findings from Taylor & Francis noted that creatine may support memory, mood, and cognitive processing speed, particularly in people whose baseline levels are already low. The CONCRET-MENOPA trial's sixteen-point-four percent increase in frontal brain creatine represents the first direct human evidence of this effect in menopausal women—the same mechanism Berry has credited with sharpening her thinking.
Safety concerns have not materialized in the available data. A comprehensive 2025 analysis of 685 clinical trials found no significant difference in adverse event rates between creatine and placebo groups, according to the Journal of the International Society of Sports Nutrition review. The CONCRET-MENOPA trial reported no severe adverse effects in its perimenopausal and menopausal participants. Women with existing kidney disease or those taking other medications should consult a clinician before starting, but for the general population, long-term use appears well-tolerated.
The dosing guidance is straightforward. The standard recommendation is three to five grams per day of creatine monohydrate, with no loading phase necessary. For cognitive benefits in menopausal women, creatine HCl at lower doses of 750 to 1,500 milligrams per day showed promise in the CONCRET-MENOPA results. Timing of intake matters less than consistency; muscle, strength, and cognitive effects emerge only after weeks and months of daily supplementation. The shift in creatine's audience reflects not a change in the compound itself but a widening recognition that its benefits extend well beyond the gym.
Citações Notáveis
Halle Berry told her podcast audience she takes creatine daily and credits it for helping her think more clearly during menopause, after initially associating the supplement with bulking.— Halle Berry, via podcast
Quer a matéria completa?
Leia o original em Us Weekly ↗
Science & Space